Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
pmid: | ||||
Salcedo M et al. | The marine sphingolipid-derived compound ES 285 triggers an atypical cell death pathway. | 2007 | Apoptosis | pmid:17191124 |
Stokvis E et al. | A more sensitive MS detector does not obviously lead to a more sensitive assay: experiences with ES-285. | 2004 | Biomed. Chromatogr. | pmid:15273982 |
Schöffski P et al. | Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies. | 2011 | Cancer Chemother. Pharmacol. | pmid:21465314 |
Cuadros R et al. | The marine compound spisulosine, an inhibitor of cell proliferation, promotes the disassembly of actin stress fibers. | 2000 | Cancer Lett. | pmid:10754202 |
FabiÅ¡Ãková M et al. | Total synthesis and the anticancer activity of (+)-spisulosine. | 2016 | Carbohydr. Res. | pmid:27693911 |
Merrill AH | Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. | 2011 | Chem. Rev. | pmid:21942574 |
Xu K et al. | A highly anti-selective asymmetric Henry reaction catalyzed by a chiral copper complex: applications to the syntheses of (+)-spisulosine and a pyrroloisoquinoline derivative. | 2012 | Chemistry | pmid:22907874 |
Kowluru A | Deoxysphingolipids: β-cell, beware of these new kids on the block. | 2014 | Diabetes | pmid:24651803 |
Zuellig RA et al. | Deoxysphingolipids, novel biomarkers for type 2 diabetes, are cytotoxic for insulin-producing cells. | 2014 | Diabetes | pmid:24379346 |